IV型肝门部胆管癌单侧塑料内支架置入治疗的前瞻性研究
作者:
通讯作者:
作者单位:

作者简介:

蔡云峰E-mail:yfcai70@yahoo.com.cn

基金项目:


A prospective study of unilateral placement of plastic stents for Bismuth type IV hilar cholangiocarcinoma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:探讨IV型肝门部胆管癌患者经ERCP置入单侧塑料内支架进行减黄治疗的效果。
    方法:对4年间42例不能切除的IV型肝门部胆管癌患者行单侧塑料内支架置入术。均经ERCP操作成功置入单侧塑料内支架引流,观察30 d内的早期操作相关并发症、病死率以及超过30 d的远期效果、生存率等。
    结果:42例患者均成功引流,85.7%(36/42)患者黄疸缓解(胆红素水平<51.3 μmol/L),平均总胆红素水平从(332.3±163.4)μmol/L降至(30.6±18.5)μmol/L。其中61.9%(26/42)的患者胆红素水平降到正常(<17.1 μmol/L)。早期并发症包括EST所致的乳头岀血(9.5%)及操作所致的胆管炎(23.8%)。无早期死亡患者。所有病例均需要定期换管。首次中位换管时间为65 d;中位内支架引流时间为5.15个月;中位生存时间为6.5个月。上述3指标左右侧组差异无统计学意义。
    结论:置入单侧塑料内支架对不可切除的肝门部胆管癌患者是安全、可行的,且可以获得较长时间的充分引流,可改善患者的生存质量和生存时间。

    Abstract:

    Objective: To explore the clinical effects of unilateral placement of plastic stents by ERCP for nonresectable Bismuth type IV hilar cholangiocarcinoma.
     Methods: A prospective study  was conducted in 42 patients with nonresectable Bismuth type IV hilar cholangiocarcinoma, who had unilateral insertion of plastic stents in the recent 4 years, All of the patients had successful insertion of single plastic stent by ERCP manipulation. Early results (less than 30 days) of procedure-related complications, mortality, long-term results (greater than 30 days)  and survival were observed.
     Results: All of the 42 patients had successful drainage. Mean total bilirubin value decreased from (332.3±163.4)μmol/L to (30.6±18.5)μmol/L, and complete resolution of jaundice was achieved in 61.9% (26/42)of the patients. Early comlications included papilla bleeding due to EST in 4 of 42 patients (9.5%) and acute cholangitis in 10 of 42 patients (23.8%). No procedure-related death occurred. All of the patients needed to have their stents replaced periodically, and the median duration up to the first stent replacement was 65 d, and without significant differences between the two groups in stent insertion to the left and right hepatic duct. Median duration of stent patency was 5.15 months, and median patient survival was 6.5 months,but also no significant differences were found between the two groups.
     Conclusions: Unilateral plastic stent insertion is safe and feasible, can achieve adequate drainage for relatively long time, and can improve life quality and survival for patients with nonresectable hilar cholangiocarcinoma.

    参考文献
    相似文献
    引证文献
引用本文

蔡云峰|苏树英|费凛|李杰原. IV型肝门部胆管癌单侧塑料内支架置入治疗的前瞻性研究[J].中国普通外科杂志,2010,19(2):180-183.
DOI:10.7659/j. issn.1005-6947.2010.02.020

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2009-11-10
  • 最后修改日期:2009-12-31
  • 录用日期:
  • 在线发布日期: 2010-02-15